Given that Chlamydia infection has been associated with an increased risk for developing cervical and ovarian cancers (46, –, 48), it would be interesting to determine whether the activation of the ARF1-RhoA signaling axis contributes to the potentiation of cancer development in those with a history of chronic Chlamydia infection. The gene discussed is RHOA; the disease is ovarian carcinoma.